Pyroptosis in Kidney Disease

被引:38
|
作者
Wang, Yujia [1 ]
Li, Yinshuang [1 ]
Xu, Yanfang [1 ]
机构
[1] Fujian Med Univ, Affiliated Hosp 1, Blood Purificat Res Ctr, Dept Nephrol, Fuzhou 350005, Peoples R China
基金
中国国家自然科学基金;
关键词
Pyroptosis; Kidney disease; ENDOPLASMIC-RETICULUM STRESS; NONCANONICAL INFLAMMASOME ACTIVATION; PROGRAMMED CELL-DEATH; TOLL-LIKE RECEPTOR; NLRP3; INFLAMMASOME; GASDERMIN D; DIABETIC-NEPHROPATHY; OXIDATIVE STRESS; BAY; 11-7082; MOLECULAR-MECHANISMS;
D O I
10.1016/j.jmb.2021.167290
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In the last several decades, apoptosis interference has been considered clinically irrelevant in the context of renal injury. Recent discovery of programmed necrotic cell death, including necroptosis, ferroptosis, and pyroptosis refreshed our understanding of the role of cell death in kidney disease. Pyroptosis is characterized by a lytic pro- inflammatory type of cell death resulting from gasdermin-induced membrane permeabilization via activation of inflammatory caspases and inflammasomes. The danger-associated molecular patterns (DAMPs), alarmins and pro-inflammatory cytokines are released from pyroptotic cells in an uncontrolled manner, which provoke inflammation, resulting in secondary organ or tissue injuries. The caspases and inflammasome activation-related proteins and pore-forming effector proteins known as GSDMD and GSDME have been implicated in a variety of acute and chronic microbial and non-microbial kidney diseases. Here, we review the recent advances in pathological mechanisms of pyroptosis in kidney disease and highlight the potential therapeutic strategies in future. (c) 2021 Elsevier Ltd. All rights reserved.
引用
收藏
页数:17
相关论文
共 50 条
  • [41] Pyroptosis and Sarcopenia: Frontier Perspective of Disease Mechanism
    Jin, Hongfu
    Xie, Wenqing
    He, Miao
    Li, Hengzhen
    Xiao, Wenfeng
    Li, Yusheng
    CELLS, 2022, 11 (07)
  • [42] ROS induced pyroptosis in inflammatory disease and cancer
    Wang, Jingsong
    Wu, Ziyong
    Zhu, Min
    Zhao, Yang
    Xie, Jingwen
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [43] Pyroptosis Inhibition in Disease Treatment: Opportunities and Challenges
    Bandharam, Navya
    Lockey, Richard F.
    Kolliputi, Narasaiah
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2023, 81 (04) : 615 - 619
  • [44] Research Progress of Pyroptosis in Alzheimer's Disease
    Xue, Weiyue
    Cui, Di
    Qiu, Ye
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2022, 15
  • [45] Ferroptosis, Pyroptosis, and Cuproptosis in Alzheimer's Disease
    Wang, Qi
    Sun, Jingyi
    Chen, Tian
    Song, Siyu
    Hou, Yajun
    Feng, Lina
    Fan, Cundong
    Li, Mingquan
    ACS CHEMICAL NEUROSCIENCE, 2023, 14 (19): : 3564 - 3587
  • [46] Research Progress of Pyroptosis in Fatty Liver Disease
    Li, Rongxuan
    Xue, Weiyue
    Wei, Huiting
    Fan, Qingqing
    Li, Xiang
    Qiu, Ye
    Cui, Di
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (17)
  • [47] Ferroptosis, Pyroptosis, and Cuproptosis in Alzheimer's Disease
    Wang, Qi
    Sun, Jingyi
    Chen, Tian
    Song, Siyu
    Hou, Yajun
    Feng, Lina
    Fan, Cundong
    Li, Mingquan
    ACS CHEMICAL NEUROSCIENCE, 2023,
  • [48] Pyroptosis in inflammation-related respiratory disease
    Feng, Yuanyu
    Li, Min
    Yangzhong, Xiaoting
    Zhang, Xifeng
    Zu, Anju
    Hou, Yunjiao
    Li, Lin
    Sun, Shibo
    JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY, 2022, 78 (04) : 721 - 737
  • [49] Pyroptosis Inhibition in Disease Treatment: Opportunities and Challenges
    Navya Bandharam
    Richard F. Lockey
    Narasaiah Kolliputi
    Cell Biochemistry and Biophysics, 2023, 81 (4) : 615 - 619
  • [50] Astragaloside IV Inhibited Podocyte Pyroptosis in Diabetic Kidney Disease by Regulating SIRT6/HIF-1α Axis
    Zhang, Mingyu
    Liu, Wenyuan
    Liu, Yuxiang
    Zhang, Ziyuan
    Hu, Yaling
    Sun, Dalin
    Li, Sufen
    Fang, Jingai
    DNA AND CELL BIOLOGY, 2023, 42 (10) : 594 - 607